These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 18975951)
1. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation. Carletti E; Li H; Li B; Ekström F; Nicolet Y; Loiodice M; Gillon E; Froment MT; Lockridge O; Schopfer LM; Masson P; Nachon F J Am Chem Soc; 2008 Nov; 130(47):16011-20. PubMed ID: 18975951 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529 [TBL] [Abstract][Full Text] [Related]
3. Structural approach to the aging of phosphylated cholinesterases. Masson P; Nachon F; Lockridge O Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153 [TBL] [Abstract][Full Text] [Related]
4. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Ekström F; Akfur C; Tunemalm AK; Lundberg S Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582 [TBL] [Abstract][Full Text] [Related]
5. Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases. Nachon F; Carletti E; Worek F; Masson P Chem Biol Interact; 2010 Sep; 187(1-3):44-8. PubMed ID: 20381476 [TBL] [Abstract][Full Text] [Related]
6. Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation. Carletti E; Colletier JP; Dupeux F; Trovaslet M; Masson P; Nachon F J Med Chem; 2010 May; 53(10):4002-8. PubMed ID: 20408548 [TBL] [Abstract][Full Text] [Related]
7. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging. Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209 [TBL] [Abstract][Full Text] [Related]
8. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes. Ekström FJ; Astot C; Pang YP Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135 [TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates. Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909 [TBL] [Abstract][Full Text] [Related]
10. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764 [TBL] [Abstract][Full Text] [Related]
11. [Aging of cholinesterase after inhibition by organophosphates]. Curtil C; Masson P Ann Pharm Fr; 1993; 51(2):63-77. PubMed ID: 8250487 [TBL] [Abstract][Full Text] [Related]
12. Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterases. Calić M; Bosak A; Kuca K; Kovarik Z Chem Biol Interact; 2008 Sep; 175(1-3):305-8. PubMed ID: 18501885 [TBL] [Abstract][Full Text] [Related]
13. Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase. Masson P; Gouet P; Clery C J Mol Biol; 1994 May; 238(3):466-78. PubMed ID: 8176737 [TBL] [Abstract][Full Text] [Related]
14. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. Sanson B; Nachon F; Colletier JP; Froment MT; Toker L; Greenblatt HM; Sussman JL; Ashani Y; Masson P; Silman I; Weik M J Med Chem; 2009 Dec; 52(23):7593-603. PubMed ID: 19642642 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
16. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase. Tenberken O; Thiermann H; Worek F; Reiter G Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021 [TBL] [Abstract][Full Text] [Related]
17. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134 [TBL] [Abstract][Full Text] [Related]
18. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040 [TBL] [Abstract][Full Text] [Related]